IRON DEFICIENCY CONDITIONS IN PREGNANT WOMEN AND PUERPERAS
https://doi.org/10.21518/2079-701X-2017-13-58-62
Abstract
The frequency of iron-deficiency conditions (IDC) in pregnant women in the world ranges from 25 to 50% at the average. In developing countries, their prevalence ranges from 35 to 75%, and in developed ones amounts to 18-20%. According to the Ministry of Health of Russia, the average frequency of IDC in pregnant women in Russia ranges from 39 to 44%, and in postpartum women – from 24% to 27% [1–3].
Iron deficiency (ID) adversely affects pregnancy, childbirth, postpartum period, fetus and newborn conditions, contributing to the increase in the frequency of threatened abortion, placental insufficiency, delayed growth and fetal hypoxia, premature birth, uterine inertia, frequency and volume of pathological blood loss in childbirth and the early postpartum period, infectious complications and hypogalactia in postpartum women. Iron supplementation to prevent reduces the risk of anemia in motherto-time delivery by 70% and iron-deficiency States by 57%.
In the modern market of pharmaceutical industry the drug Sorbifer Durules has been well established (EGIS, Hungary). The use of this drug in a large sample of pregnant and postpartum women in recent years has proved its efficacy in the treatment of ID in this patient cohort.
About the Authors
V. L. Tyutyunnik
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD,
Moscow
N. E. Kan
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Russian Federation
MD,
Moscow
N. A. Lomova
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Moscow
Russian Federation
Moscow
R. S.-E. Dokueva
Kulakov Scientific Center of Obstetrics, Gynecology and Perinatology of the Ministry of Health of Russia
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Бурлев В.А., Коноводова Е.Н. Железодефицитные состояния у беременных и родильниц. Рациональная фармакотерапия в акушерстве и гинекологии. 2-е изд. испр и доп. Под ред. В.Н. Серова и Г.Т. Сухих. Т.1. Акушерство и неонатология. М., 2010: 393-405.
2. Коноводова Е.Н., Бурлев В.А., Тютюнник В.Л., Якунина Н.А., Подымова А.А. Эффективность терапии латентного дефицита железа у беременных. Вопросы гинекологии, акушерства и перинатологии, 2011, 10(5): 26-30.
3. Лечение манифестного дефицита железа у беременных и родильниц. Медицинская технология Серов В.Н., Бурлев В.А., Коноводова Е.Н., Орджоникидзе Н.В., Тютюнник В.Л. Разрешение Федеральной Службы по надзору в сфере здравоохранения и социального развития. Серия АА 0000151, ФС № 2010/003 от 18 января 2010 г.
4. Профилактика манифестного дефицита железа у беременных и родильниц. Медицинская технология. Серов В.Н., Бурлев В.А., Коноводова Е.Н., Орджоникидзе Н.В., Тютюнник В.Л., Протопопова Т.А. Разрешение Федеральной Службы по надзору в сфере здравоохранения и социального развития. Серия АА 0000150, ФС№ 2010/004 от 18 января 2010 г.
5. Серов В.Н., Бурлев А.В., Коноводова Е.Н. и соавт. Диагностика, профилактика и лечение железодефицитных состояний у беременных и родильниц (клинический протокол). Акушерство и гинекология, 2014, 3 (приложение): 11-17.
6. Tayupova IM. To the question of rational nutrition, micronutrient status correction, prevention and treatment of iron deficiency in pregnancy. Vopr Pitan., 2015, 84(2): 25-33.
7. Beucher G, Grossetti E, Simonet T et al. Iron deficiency anemia and pregnancy. Prevention and treatment. J. Gynecol. Obstet. Biol. Reprod., 2011, 40(3): 185-200.
8. Cantor AG, Bougatsos C, Dana T, Blazina I, McDonagh M. Routine iron supplementation and screening for iron deficiency anemia in pregnancy: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med, 2015, 162: 566–76.
9. Breymann C, Honegger C, Holzgreve W, Surbek D. Diagnosis and treatment of iron-deficiency anaemia during pregnancy and postpartum. Arch. Gynecol. Obstet., 2010, 282(5): 577-80
10. Mireku MO, Davidson LL, Boivin MJ, Zoumenou R, Massougbodji A, Cot M, Bodeau-Livinec F. Prenatal Iron Deficiency, Neonatal Ferritin, and Infant Cognitive Function. Pediatrics, 2016 Dec, 138(6). pii: e20161319.
11. Kozuki N, Lee AC, Katz J. Moderate to severe, but not mild, maternal anemia is associated with increased risk of small-for-gestationalage outcomes. J Nutr, 2012, 142(2): 358-62.
12. Iglesias L, Canals J, Arija V. Effects of prenatal iron status on child neurodevelopment and behavior: A systematic review. Crit Rev Food Sci Nutr, 2017 Jan 13:0. doi: 10.1080/10408398.2016.1274285.
13. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev, 2015, 7: CD004736.
14. Choudhury N, Aimone A, Hyder SM, Zlotkin SH. Relative efficacy of micronutrient powders versus iron-folic acid tablets in controlling anemia in women in the second trimester of pregnancy. Food Nutr Bull., 2012, 33(2): 142-9.
15. Drukker L, Hants Y, Farkash R et al. Iron deficiency anemia at admission for labor and delivery is associated with an increased risk for Cesarean section and adverse maternal and neonatal outcomes. Transfusion, 2015. doi: 10.1111/trf.13252.
16. Khalafallah AA, Dennis AE, Ogden K et al. Three-year follow-up of a randomised clinical trial of intravenous versus oral iron for anaemia in pregnancy. BMJ Open, 2012, 18: 2-5.
17. Pena-Rosas JP, De-Regil LM, Garcia-Casal MN, Dowswell T. Daily oral iron supplementation during pregnancy. Cochrane Database Syst Rev, 2015, 7: CD004736.
18. Christoph P, Schuller C, Studer H et al. Intravenous iron treatment in pregnancy: comparison of high-dose ferric carboxymaltose vs. iron sucrose. J Perinat Med, 2012, 13, 40(5): 469-74.
19. Kochhar PK, Kaundal A, Ghosh P. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: A randomized clinical trial. J. Obstet. Gynaecol. Res., 2012, 26: 1-7.
20. Breymann C, Milman N, Mezzacasa A, Bernard R, Dudenhausen J. Ferric carboxymaltose vs. oral iron in the treatment of pregnant women with iron deficiency anemia: an international, open-label, randomized controlled trial (FER-ASAP). J Perinat Med, 2016 Jun 8. pii: /j/jpme.ahead-of-print/jpm-2016-0050/ jpm-2016-0050.xml. doi: 10.1515/jpm-2016-0050.
21. Froessler B, Collingwood J, Hodyl NA, Dekker G. Intravenous ferric carboxymaltose for anaemia in pregnancy. BMC Pregnancy Childbirth, 2014, 14: 115.
Review
For citations:
Tyutyunnik VL, Kan NE, Lomova NA, Dokueva RS. IRON DEFICIENCY CONDITIONS IN PREGNANT WOMEN AND PUERPERAS. Meditsinskiy sovet = Medical Council. 2017;(13):58-62. (In Russ.) https://doi.org/10.21518/2079-701X-2017-13-58-62
Views:
767
Email this article 